Together, the defined clock subtypes offer a complementary viewpoint on the subtyping of breast cancer which could refine the assessment of cancer models for circadian-aligned therapeutic strategies and improve the prediction of their outcomes. The gene discussed is CLOCK; the disease is breast cancer.